RxDoctor Payments Data

Roger Hajjar

Cardiovascular Disease · New York, NYNPI 1003801903

Payments from drug & device makers

What this record shows

This record is dominated by other: $5,163,656 of the $5,164,409 with a category attached, or 100.0%. Asklepios Biopharmaceutical Inc. accounts for 88.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $2,429,895 and has fallen 100.0% since, to $21 in 2025. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,164,409in general payments, 2019–2025

Across 8 payments — averaging $645,551 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Asklepios Biopharmaceutical Inc.$4.5M
  • Bayer$620K
  • Abiomed$732
  • AstraZeneca$21

What the payments were for

  • Travel & lodging$7320%
  • Food & beverage$210%
  • Other$5,163,656100%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Asklepios Biopharmaceutical Inc.2$4,543,973
Bayer1$619,683
Abiomed4$732
AstraZeneca1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,164,409 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Other cardiovascular disease in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →